NEWS - EU NEWS
EMEA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)
CPME publication date: Monday, November 23, 2009Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 16-19 November 2009:
Efficacy and safety of H1N1 pandemic vaccines reaffirmed The European Medicines Agency has reviewed further data on the centrally authorised pandemic vaccines, Celvapan, Focetria and Pandemrix. The Agency has reaffirmed that they have a positive balance of benefits and risks in the context of the current H1N1 influenza pandemic.
A separate press release is available here.
back to EU News Index